Xencor Inc. Stock
Price
Target price
?
?
-1.520%
-0.3
-1.520%
€22.84
08:32 / Stuttgart Stock Exchange
WKN: A1W96L / Symbol: XNCR / Name: Xencor / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Xencor Inc. Stock
A loss of -1.520% shows a downward development for Xencor Inc..
We see a rather positive sentiment for Xencor Inc. with 15 Buy predictions and 1 Sell predictions.
As a result the target price of 22 € shows a slightly positive potential of 12.82% compared to the current price of 19.5 € for Xencor Inc..
Pros and Cons of Xencor Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Xencor Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Xencor Inc. | -1.520% | 6.989% | 29.221% | 206.154% | 56.693% | -2.451% | -25.635% |
| Ligand Pharmaceuticals | -0.800% | 0.787% | -1.538% | 93.939% | 54.217% | 306.349% | 181.133% |
| United Therapeutics | -0.110% | -4.378% | -6.217% | 64.112% | 2.738% | 109.247% | 158.235% |
| Ionis Pharmaceuticals Inc. | 1.900% | 2.697% | 6.476% | 35.329% | -25.486% | 40.706% | 53.083% |
Comments
Xencor (XNCR) had its price target raised by Wedbush from $26.00 to $30.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for XNCR provided by MarketBeat
Xencor (XNCR) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Show more
Ratings data for XNCR provided by MarketBeat
Xencor (XNCR) had its "outperform" rating reaffirmed by Wedbush. They now have a $26.00 price target on the stock.
Show more
Ratings data for XNCR provided by MarketBeat

